Editor's key points † Inferior vena cava (IVC) filters are used for prevention of venous thromboembolism when prophylactic anticoagulation is contraindicated. † Risk factors for complications from retrievable IVC filters were studied in a retrospective single-centre analysis of trauma patients. † High injury severity score, tibial/fibular fractures, delayed pharmacological thromboprophylaxis, and filters left in situ for .50 days were significant risk factors for complications.
Results. Of the 2940 major trauma patients admitted during the study period, a retrievable IVC filter was used in 223 patients (7.6%). Thirty-six patients (16%) developed DVTor VTE subsequent to placement of IVC filters (median 20 days, interquartile range 9-33), including 27 with lower limb (DVT), 8 upper limb DVT, and 4 pulmonary embolism. A high Injury Severity Score, tibial/ fibular fractures, and a delay in initiating pharmacological thromboprophylaxis after insertion of the filters (14 vs 7 days, P¼0.001) were significant risk factors. Thirty patients were lost to follow-up (13%) and their filters were not retrieved. Mechanical complications-including filters adherent to the wall of IVC (4.9%), IVC thrombus (4.0%), and displaced or tilted filters (2.2%)-were common when the filters were left in situ for .50 days.
Conclusions.
A delay in initiating pharmacological thromboprophylaxis or filter removal were associated with an increased risk of subsequent DVT, VTE, and mechanical complications of retrievable IVC filters in patients after major trauma.
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Venous thromboembolism (VTE) is very common in critically injured patients and is associated with substantial morbidity and mortality. 1 2 Evidence suggests that thromboprophylaxis is of paramount importance in reducing mortality and morbidity of VTE, but recent studies showed that many critically ill, including patients with major trauma, remained untreated with thromboprophylaxis in a timely fashion. 3 As bleeding from pharmacological thromboprophylaxis is a predictor of death, 4 mechanical thromboprophylaxis including inferior vena cava (IVC) filters is increasingly used in patients with major trauma who have an increased risk of bleeding. 5 Although IVC filters have been used for thromboprophylaxis for many years, there is only one randomized clinical trial evaluating the benefits and risks of using permanent IVC filters for secondary prophylaxis in patients with proven proximal deep vein thrombosis (DVT). 6 This randomized controlled study showed that permanent IVC filters did not reduce the long-term risk of pulmonary embolism (PE) or mortality, but their long-term use was associated with an increase in risk of recurrent lower limb DVT. Temporary and retrievable IVC filters can be removed when the risk of VTE or bleeding has subsided and have largely replaced permanent IVC filters in the acute trauma care setting when an IVC filter is indicated. However, recent evidence suggested that many temporary IVC filters were not retrieved in due course, and VTE including PE still occurred despite the presence of an IVC filter. 7 Although the complications of many older permanent IVC filters have been well described, the safety of the newer retrievable IVC filters-including the incidence of and risk factors for subsequent VTE and mechanical complicationsremains unclear. 8 9 In this retrospective cohort study, we assessed the incidence and risk factors of DVT and VTE and mechanical complications subsequent to placement of retrievable IVC filters in a cohort of patients with major trauma.
Methods
After obtaining approval from the Royal Perth Hospital Ethics Committee (EC 2012/115), the Western Australian Trauma Registry data of all major trauma patients who had a retrievable IVC filter for VTE prophylaxis between 1 January 2007 and 31 December 2012 were linked to the radiology database and death registry and the data were cross checked by two investigators. Royal Perth Hospital, a university teaching hospital, is the state of Western Australia's largest trauma centre, and admits about 4000 -6000 adult trauma patients including burns, cardiothoracic, spinal and head trauma, per annum. The standard thromboprophylaxis for all injured patients included elastic stockings, intermittent pneumatic compression devices to the lower limbs when there was no physical injury to the legs, and unfractionated heparin 5000 units twice or thrice daily if the patients were not at risk of bleeding. Low-molecular-weight heparin (subcutaneous enoxaparin 40 mg daily) was also used occasionally in patients who were deemed to be not at risk of bleeding. Retrievable IVC filters (Bard w G2 and G2X, C.R. Bard, Inc. New Jersey, USA) were used as primary VTE prophylaxis if pharmacological thromboprophylaxis was contraindicated within the first 3 to 7 days of injury because of bleeding risk and intermittent pneumatic compression to the lower limbs was not possible because of lower limb injuries, or when using intermittent pneumatic compression alone for a prolonged period of time was considered inadequate to prevent fatal PE (e.g. a patient with pelvic fractures, abdominal visceral organ injury, and severe brain injury requiring multiple operations within the first 7-10 days after hospital admission). IVC filters were used for secondary VTE prophylaxis in patients who had documented symptomatic VTE but with contraindications to systemic anticoagulation.
In this study, only trauma patients with an Injury Severity Score (ISS)≥15 were analysed. 10 All data were collected for clinical reasons and were retrospectively retrieved from the medical records and radiology database. Risk factors for DVT and VTE subsequent to insertion of IVC filters analysed in this study included age, sex, ISS, regions of injury, body weight, interventions such as intracranial pressure monitor and mechanical ventilation, use of the IVC filter as primary or secondary VTE prophylaxis, and time to initiate pharmacological thromboprophylaxis (or systemic anticoagulation for those with VTE before pharmacological thromboprophylaxis was initiated) after insertion of the IVC filters. The latter information was retrieved from the anticoagulation chart of each patient. Outcomes included symptomatic lower limb and upper limb DVT, PE, and mechanical complications noted when attempts to remove the IVC filters were made. The mechanical complications analysed in this study included filter adherent to or penetrating the IVC wall, IVC thrombosis occluding the filter requiring systemic anticoagulation for 8-10 weeks before a second attempt at removal, and filters that were displaced or tilted within the IVC reducing its effectiveness in trapping emboli from the lower limbs. Outcome events included in this study were symptomatic DVTand PE confirmed by colour Doppler compression ultrasound and CT pulmonary angiography, respectively. Outcome events, mechanical complications related to the IVC filters, and mortality were assessed on 14th May 2013. Because this was a retrospective study, radiologists who reported DVT or VTE events and mechanical complications related to IVC filters were unaware of the initiation or design of this study.
Statistical analysis
A sample size of over 200 was needed to assess up to five independent risk factors subsequent to the insertion of the IVC filters if the incidence of DVTor VTE of the major trauma patients with an IVC filter was 25%. Categorical variables were analysed using a x 2 test, and continuous variables with skewed distributions were analysed using a Mann-Whitney test. We used Cox proportional hazards regression to assess plausible risk factors, including the pattern and severity of injury and use of clinical interventions, associated with the time to first subsequent DVT or VTE after filter insertion. Variables entered into the multivariate analysis were eliminated, in a stepwise fashion, if their associated P-value was .0.25 to improve precision of the results of the final model. A Kaplan-Meier hazard curve was used to assess whether major mechanical complications related to IVC filters were related to duration of the filters left in situ. A P-value of ,0.05 was taken as significant, and all tests were two-tailed and performed using SPSS for Windows (version 19.0, IBM, Version 19.0, Armonk, NY, USA, 2011).
Results

DVT or VTE subsequent to insertion of IVC filters
A total of 2940 major trauma (ISS≥15) and 28 806 minor trauma (ISS,15) patients were admitted to the study centre between 2007 and 2012. Of the 2940 major trauma patients, a retrievable IVC filter was used in 223 patients (7.6%) with 201 filters used for primary VTE prophylaxis because of the presence of contraindications to other forms of thromboprophylaxis and 22 filters used for secondary VTE prophylaxis after symptomatic DVT or VTE was diagnosed and systemic anticoagulation was considered contraindicated (Fig. 1 (Fig. 2) ; this risk factor fulfilled the proportionality assumption of the Cox regression. Although the mortality of those with DVT or VTE subsequent to the insertion of IVC filters appeared to be higher than those without, this difference was not statistically different both with and without adjusting for ISS (Table 1) . Fatal PE was not observed in the 14 patients who had post-mortem examination.
Mechanical complications related to retrievable IVC filters
Of the 36 patients who had subsequent DVTor VTE after filter insertion, 13 (36%) also had at least one form of mechanical complication or were lost to follow-up. A total of 50 patients had at least one mechanical complication or were lost to follow-up, and 13 of these (26%) also had symptomatic DVT or VTE subsequent to filter insertion ( out of 223 (33%) had either a new DVTor VTE, mechanical complication, or were lost to follow-up subsequent to filter insertion for primary or secondary VTE prophylaxis.
Of the 223 included in the study, 30 patients were lost to follow-up (13%) and their IVC filters were not retrieved. After excluding these 30 patients, the median time to filter retrieval was 79 days (IQR 48-128 days). Mechanical complications, including adherence to the wall of IVC (4.9%; 0.72 per 1000 patient-days, 95% CI 0.36-1.29), IVC thrombus occluding the filter (4.0%; 0.59 per 1000 patient-days, 95% CI 0.27 -1.12), and displaced or tilted filter within the IVC (2.2%), at the time of first attempt to remove the IVC filters were common. The risk of these mechanical complications increased substantially when filters were left in situ for .50 days (Figs 3 and 4) . Filters that were adherent to or penetrated through the wall of the IVC filters were not retrieved. Those patients who had IVC thrombosis received systemic anticoagulation for 2 months, and all these filters were successfully retrieved subsequently.
Discussion
Our results showed that venous thrombotic, thromboembolic, and mechanical complications after using retrievable IVC filters in patients with major trauma were common (33%). A delay in initiating pharmacological thromboprophylaxis after filter insertion was an important preventable risk factor for subsequent DVT or VTE, and the risk of mechanical complications increased substantially with duration of filters left in situ.
The reason why many patients who had an IVC filter for primary VTE prophylaxis did not receive pharmacological thromboprophylaxis earlier was likely because of the common misconception that an IVC filter was sufficient in preventing all forms of VTE in patients at risk. Indeed, our results are consistent with recent observational studies on retrievable IVC filters that VTE including PE could still occur despite the presence of an IVC filter. 7 9 The possible mechanisms for PE occurrence despite the presence of an IVC filter may include clots originating from the upper limbs, de novo thrombosis formation in the pulmonary circulation, 11 and ineffective trapping of embolus from the lower limbs if the IVC filter is tilted or displaced. Our results suggested that while IVC filters might be very effective in preventing fatal PE, they are inadequate alone to prevent all DVT and VTE events and should best be used as a bridging measure with pharmacological thromboprophylaxis initiated as soon as possible. Practically, most IVC filters are used for primary VTE prophylaxis within the first 7-10 days after major trauma when patients are at highest risk of bleeding. In the later phase of major trauma, evidence suggests that many patients become prothrombotic. 12 13 As such, initiating pharmacological thromboprophylaxis as soon as bleeding risk has subsided, possibly within 7-10 days after filter insertion, should be considered to minimize the risk of DVT and VTE complications. Although retrievable IVC filters can theoretically be removed when bleeding risk has subsided and pharmacological thromboprophylaxis can be commenced, we noted that the median time to retrieve filters was much longer than the time to initiate pharmacological thromboprophylaxis for most patients. The clinical imperative for leaving an IVC filter in situ beyond the time without pharmacological thromboprophylaxis is to confer additional protection against PE for patients remaining at high risk of VTE. This hypothetical benefit must be balanced with the increased risk of mechanical complications when filters are left in situ for too long. Our study showed that the risk of filters adherent to or penetrating through the wall of IVC, and also IVC thrombosis, increased substantially with time, especially after 50 days, suggesting that mechanical complications might be substantially reduced if retrievable IVC filters are removed within 50 days or soon after pharmacological thromboprophylaxis has commenced.
14 Instead of leaving IVC filters in situ for patients who remain at high risk of VTE when pharmacological thromboprophylaxis alone is considered inadequate, other alternatives such as combining intermittent pneumatic compression of the lower limbs with pharmacological thromboprophylaxis 15 16 or systemic anticoagulation should also be considered. Furthermore, leaving IVC filters in situ for a prolonged period of time also runs a risk of leaving filters not retrieved when patients are lost to follow-up. Since we implemented strict Western Australia state-wide guidelines and protocols on removal of temporary IVC filters before 60 days, the number of patients without filters retrieved because of lost to follow-up has substantially reduced (unpublished observations). This study has some limitations. First, the incidence of DVT or VTE was relatively low (16%), reducing the precision of the results and the statistical power of the study to identify multiple risk factors subsequent to filter insertion. This was a single-centre study and we used only one particular brand of retrievable IVC filters. As such, confirmation of our results by other centres is required.
14 Secondly, we had data only on symptomatic DVT and PE. Whether the incidence of asymptomatic DVT and PE after insertion of IVC filters for primary VTE prophylaxis in patients with major trauma is much higher than symptomatic DVTor VTE remains uncertain. Furthermore, there are also limitations in using Doppler ultrasound (sensitivity 85% and specificity 88% in detecting symptomatic proximal DVT) to diagnose symptomatic DVT, and hence the true incidence of DVTafter the use of an IVC filter could be higher than we reported. 17 Finally, our previous study showed that the risk of symptomatic DVT or VTE in patients after major trauma who had no contraindications to pharmacological thromboprophylaxis and not requiring an IVC filter was about 2.8%. 2 These data suggest that the presence of an IVC filter might have, in part, contributed to the increased risk of DVT or VTE (16%) reported in this study. Nevertheless, this comparison is not fully valid because patients with and without contraindications to pharmacological thromboprophylaxis are intrinsically different. As such, we could not confirm whether using IVC filters for primary prophylaxis would be beneficial or harmful compared with placebo in major trauma patients who have contraindications to all thromboprophylaxis. An adequately powered randomized controlled study evaluating the benefits, harms, and costeffectiveness of using IVC filters for primary thromboprophylaxis in patients who have contraindications to other forms Table 3 Incidence of problems or complications encountered subsequent to placement of a retrievable IVC filter as primary or secondary VTE prophylaxis for patients with major trauma (n¼223). *Three patients had both upper and lower limb DVT subsequent to placement of an IVC filter and 13 (36%) of the 36 patients who had subsequent DVTE or VTE also had at least one form of mechanical complications or were lost to follow-up. † Thirteen of the 50 patients (26%) who had mechanical complications or were lost to follow-up also had symptomatic thromboembolism subsequent to the insertion of an IVC filter. Together, a total of 73 patients out of 223 (33%) had either new DVTor VTE, mechanical complications or lost to follow-up subsequent to the insertion of an IVC filter for primary or secondary VTE prophylaxis of thromboprophylaxis after major trauma is thus needed. Because many VTE events are clinically silent, a proactive approach to detect mildly symptomatic or asymptomatic VTE will be essential in such a randomized controlled study. In summary, DVT, VTE, and mechanical complications after using retrievable IVC filters for VTE prophylaxis in patients with major trauma were common, especially when pharmacological thromboprophylaxis was delayed or when filters were not removed within 50 days. Until data from randomized controlled trials on cost-effectiveness and safety of using retrievable IVC filters in patients with major trauma are available, initiating pharmacological thromboprophylaxis and removing retrievable IVC filters as soon as bleeding and VTE risks have subsided are recommended.
